Physician

Albert James Mamary, MD

According to 2025 Medicare claims, Albert Mamary, MD (NPI: 1407808033) practices pulmonary disease in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN, INC (NPI: 1104309889; TIN: 831002191) and primary practice location at 19460-6127.

Mamary's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 181 traditional Medicare patients, billed 5,672 HCPCS/CPT codes, and received $162,156 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,679 prescription claims across 198 beneficiaries totaling $2,509,695 in drug costs, led by Nucala (Mepolizumab). DME data shows 1,220 claims. Open Payments data shows 2 records totaling $54. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $119,750 and ending at $162,156. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $983,386 and ending at $2,509,695. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $33,206 to $49,504.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	328	1,984	$119,750
2016	429	1,970	$118,572
2017	394	2,221	$143,691
2018	344	2,448	$139,021
2019	424	4,297	$174,596
2020	193	3,732	$119,557
2021	85	2,732	$75,302
2022	260	7,014	$202,904
2023	226	6,035	$180,644
2024	181	5,672	$162,156

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	124	1,697	$983,386
2016	157	2,658	$1,375,617
2017	206	3,162	$1,371,131
2018	189	3,489	$1,266,329
2019	181	3,716	$1,316,262
2020	161	3,091	$1,258,366
2021	110	734	$442,419
2022	155	2,415	$1,613,220
2023	179	2,592	$1,629,281
2024	198	2,679	$2,509,695

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	63	761	$42,608
2016	82	723	$36,905
2017	44	668	$26,360
2018	153	1,186	$60,727
2019	293	1,780	$84,072
2020	189	1,635	$122,204
2021	59	549	$43,751
2022	170	1,414	$92,688
2023	123	1,237	$232,206
2024	111	1,220	$325,254

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	88	147	$112
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	23	56	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	17	19	$66
99238	Hospital discharge day management, 30 minutes or less	14	14	$62
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	29	80	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nucala	Mepolizumab	64	1,792	$575,738
Prevymis	Letermovir	55	1,596	$397,463
Opsumit	Macitentan	24	720	$307,553
Ofev	Nintedanib Esylate	16	480	$208,819
Winrevair	Sotatercept-Csrk	11	231	$156,825

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J3285	Injection, treprostinil, 1 mg	N	N/R	52	$246,543
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	30	$30,110
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	26	$12,951
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	13	92	$6,512
J7682	Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams	N	N/R	12	$4,592

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$54	Avadel CNS Pharmaceuticals, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Albert James Mamary, MD?

Tedicare shows public-source Medicare data for Albert James Mamary, MD (NPI 1407808033), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albert James Mamary, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Albert James Mamary, MD?

Albert James Mamary, MD is linked to TEMPLE FACULTY PRACTICE PLAN, INC (billing NPI 1104309889) in the available physician profile data.

Does Albert James Mamary, MD have Open Payments data?

Albert James Mamary, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.